Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Dark Pool Levels

AMAG
AMAG Pharmaceuticals, Inc. Common Stock
stock NASDAQ

Inactive
Nov 13, 2020
13.75USD+0.146%(+0.02)1,534,573
Pre-market
0.00USD0.000%(0.00)0
After-hours
0.00USD0.000%(0.00)0
OverviewHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Dec 14, 2020
08:47AM EST  AMAG Pharmaceuticals, Inc. has submitted its response to the FDAs Notice of Opportunity for a Hearing (NOOH) regarding the Agencys proposal to withdraw approval for Makenaalso referred to as 17-OHPCthe only FDA-approved treatment, along with five generic versions, to reduce preterm birth in women with a singleton pregnancy who have a history of singleton spontaneous preterm birth.   GlobeNewswire Inc
Nov 16, 2020
09:26AM EST  Covis Group Completes Acquisition Of AMAG Pharmaceuticals At $13.75 Per Share   RTTNews
09:21AM EST  Covis Group Completes Acquisition of AMAG Pharmaceuticals   PR Newswire
Nov 5, 2020
07:42PM EST  MGIC Investment & Halozyme Therapeutics Set To Join S&P MidCap 400   RTTNews
06:41PM EST  MGIC Investment & Halozyme Therapeutics Set to Join S&P MidCap 400; First   PR Newswire
Nov 4, 2020
07:32PM EST  Contango Oil & Gas Company, Eaton Vance Corp., MobileIron, Inc., Seacoast Commerce Banc Holdings, Perceptron, Inc., Standard AVB Financial Corp., Virginia National Bankshares Corporation and Virtusa Corporation   PR Newswire
Oct 31, 2020
08:51PM EDT  Investigations; Investors are Encouraged to Contact the Firm - VRTU, AMAG, EV, CBMG   PR Newswire
Oct 30, 2020
03:29PM EDT  Lifshitz Law Firm, P.C. Announces Investigation of AMAG   GlobeNewswire Inc
Oct 29, 2020
07:40PM EDT  SHAREHOLDER ALERT: WeissLaw LLP Reminds PRCP, CBLI, AMAG, and MR Shareholders   PR Newswire
Oct 21, 2020
09:01PM EDT  SHAREHOLDER ALERT: WeissLaw LLP Reminds AMAG, SCBH, MR, and VRTU Shareholders   PR Newswire
11:50AM EDT  Moore Kuehn Encourages NTN, CXO, AMAG, and RESI Investors to Contact Law Firm   PR Newswire
10:10AM EDT  INVESTIGATION ALERT: Halper Sadeh LLP is Investigating the Following Companies;   PR Newswire
Oct 20, 2020
06:13PM EDT  Eaton Vance Corp., MobileIron, Inc., Seacoast Commerce Banc Holdings, Perceptron, Inc., Standard AVB Financial Corp., Virginia National Bankshares Corporation and Virtusa Corporation   PR Newswire
Oct 15, 2020
03:42PM EDT  Rigrodsky & Long, P.A. announces that it is investigating AMAG Pharmaceuticals, Inc. (AMAG) (NASDAQ GS: AMAG) regarding possible breaches of fiduciary duties and other violations of law related to AMAGs agreement to be acquired by Covis Group S..r.l. Under the terms of the agreement, AMAGs shareholders will receive $13.75 per share in cash.   GlobeNewswire Inc
12:24PM EDT  Lifshitz Law Firm, P.C. Announces Investigation of AMAG   GlobeNewswire Inc
07:53AM EDT  Covis Group S. r.l. announced the commencement of a cash tender offer to purchase all of the outstanding shares of common stock of AMAG Pharmaceuticals, Inc. (AMAG). The deal has a total enterprise value of approximately $647 million, including net debt. The tender offer will expire on November 12, 2020.   RTTNews
07:36AM EDT  Covis Group Begins Tender Offer For All Outstanding Shares Of AMAG Pharma For $13.75 Per Share   RTTNews
07:32AM EDT  Covis Group S. r.l. Announces Commencement Of Tender Offer For All Outstanding Shares Of AMAG Pharmaceuticals, Inc.   Benzinga
07:31AM EDT  Covis Group S. r.l. Announces Commencement of Tender Offer for All Outstanding   PR Newswire
Oct 14, 2020
09:16PM EDT  SHAREHOLDER ALERT: WeissLaw LLP Reminds AMAG, PTI, VRTU and GANS Shareholders   PR Newswire
04:12PM EDT  AMAG Pharma Reports Request For Hearing To Maintain Makena As Treatment Option For Clinically-Indicated Pregnant Patients   Benzinga
04:11PM EDT  AMAG Pharmaceuticals Requests Hearing to Maintain   GlobeNewswire Inc
Oct 13, 2020
06:12AM EDT  Magnetar Financial LLC Reports 6.90% Active Stake In AMAG Pharmaceuticals   Benzinga
Oct 9, 2020
05:45PM EDT  SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of   PR Newswire
02:24PM EDT  AMAG PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of AMAG Pharmaceuticals, Inc. - AMAG   Business Wire
Oct 8, 2020
01:47PM EDT  Moore Kuehn, PLLC, a securities litigation law firm located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed mergers are fair to shareholders. Moore Kuehn may ultimately seek increased consideration, additional disclosures, or other relief and benefits on behalf of the shareholders of these companies:   GlobeNewswire Inc
Oct 7, 2020
11:26AM EDT  Lifshitz Law Firm, P.C. Announces Investigation of AMAG   GlobeNewswire Inc
Oct 6, 2020
05:40AM EDT  AMAG Pharmaceuticals Provided Update on FDA's Proposal Regarding Makena; Says has 15 Days to Respond to FDA; Continues to Expect Its Recently Announced Tender Offer and Merger to Close in November 2020   Benzinga
05:39AM EDT  AMAG Pharmaceuticals Provided Update on FDA's Proposal Regarding Makena; Says 15 Days to Respond to FDA; Continues to Expect Its Recently Announced Tender Offer and Merger to Close in November 2020   Benzinga
Oct 5, 2020
11:08PM EDT  Shareholders are Encouraged to Contact the Firm - AMAG, SBPH, VAR, SINA, GARS   PR Newswire
09:10PM EDT  AMAG : FDA Proposes To Withdraw Approval Of Makena, Treatment Approved To Reduce Preterm Birth In Pregnant Women   RTTNews
09:05PM EDT  -- The product remains on the market -- AMAG has 15 days to respond to the FDA -- AMAG continues to expect itsrecently announced tender offer and merger to close in November 2020   GlobeNewswire Inc
Oct 2, 2020
08:35PM EDT  SHAREHOLDER ALERT: WeissLaw LLP Investigates AMAG Pharmaceuticals, Inc.   PR Newswire
08:01PM EDT  MobileIron, Inc., Monaker Group, Inc., Seacoast Commerce Banc Holdings, Perceptron, Inc., Standard AVB Financial Corp., Virtusa Corporation, WPX Energy, Inc. and Devon Energy Corporation   PR Newswire
03:45PM EDT  Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the board members of AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) breached their fiduciary duties or violated the federal securities laws in connection with the companys merger with Covis Group S.. r.l.   GlobeNewswire Inc
01:03PM EDT  ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of AMAG   PR Newswire
10:39AM EDT  Benzinga's Top Upgrades, Downgrades For October 2, 2020   Benzinga
08:11AM EDT  10 Biggest Price Target Changes For Friday   Benzinga
06:35AM EDT  HC Wainwright & Co. Downgrades AMAG Pharmaceuticals to Neutral, Lowers Price Target to $13.75   Benzinga
04:37AM EDT  SVB Leerink Maintains Market Perform on AMAG Pharmaceuticals, Raises Price Target to $13.65   Benzinga
Oct 1, 2020
02:47PM EDT  Mid-Afternoon Market Update: Nasdaq Jumps 150 Points; Selecta Biosciences Shares Plunge   Benzinga
02:12PM EDT  AMAG Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of AMAG Pharmaceuticals, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm - AMAG   Business Wire
12:27PM EDT  Piper Sandler Upgrades AMAG Pharmaceuticals to Neutral   Benzinga
10:47AM EDT  CORRECTION: Covis Group Announces Agreement To Acquire AMAG Pharmaceuticals For $13.75/Share For ~$647M   Benzinga
10:45AM EDT  Addition of AMAGs category leading treatments positions Covis to become a global market leader of therapeutic solutions for life-threatening conditions and chronic illnesses   GlobeNewswire Inc
09:26AM EDT  ROCE Insights For AMAG Pharmaceuticals   Benzinga
Sep 30, 2020
04:34PM EDT  AMAG Pharmaceuticals Shares Spike Higher, Up 37%; Apollo's Covis Said To Be In Talks To Buy Co   Benzinga
Sep 9, 2020
08:00AM EDT  AMAG Pharmaceuticals, Inc.(NASDAQ: AMAG) today announced that Scott Myers, Chief Executive Officer, and Brian Piekos, Chief Financial Officer, will participate in a fireside chat at the H.C. Wainwright 22nd Annual Global Investment Conference on Tuesday, September 15, 2020 at 10:30 a.m. Eastern Time.   GlobeNewswire Inc
Aug 18, 2020
09:48AM EDT  Benzinga's Top Upgrades, Downgrades For August 18, 2020   Benzinga
07:29AM EDT  Barclays Downgrades AMAG Pharmaceuticals to Equal-Weight, Announces $10 Price Target   Benzinga
Aug 7, 2020
05:41AM EDT  SVB Leerink Maintains Market Perform on AMAG Pharmaceuticals, Raises Price Target to $10   Benzinga
Aug 6, 2020
11:05AM EDT  HC Wainwright & Co. Maintains Buy on AMAG Pharmaceuticals, Raises Price Target to $14   Benzinga
09:02AM EDT  AMAG Pharmaceuticals Sees FY20 Sales vs $225M-$255M vs $250.01M Est.   Benzinga
09:01AM EDT  AMAG Pharmaceuticals Earlier Reported Q2 EPS $(0.39) Misses $(0.19) Estimate, Sales $52.80M Miss $57.95M Estimate   Benzinga
07:57AM EDT  The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Bristol-Myers Squibb Earnings, Acutus Medical IPO   Benzinga
07:19AM EDT  Biocryst Pharmaceuticals Q2 EPS $(0.24) Beats $(0.25) Estimate   Benzinga
07:01AM EDT  Financial guidance reissued to include EBITDA-positive projection for second-half 2020   GlobeNewswire Inc
Jul 28, 2020
08:01AM EDT  AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that its second quarter 2020 financial results will be released on Thursday, August 6, 2020 before the U.S. financial markets open. Management will host a conference call and webcast at 8:00 a.m. ET to discuss the results and provide an update on recent corporate developments.   GlobeNewswire Inc
Jul 27, 2020
07:35AM EDT  AMAG, Palatin Technologies Mutually Terminate January 2017 License Agreement   RTTNews
07:34AM EDT  AMAG Pharmaceuticals Completes Divestment Of Women's Health Assets   Benzinga
07:30AM EDT  AMAG Pharmaceuticals Completes Divestment of   GlobeNewswire Inc
07:03AM EDT  Palatin Technologies Terminates its Agreement Granting AMAG Pharma Exclusive North American Reights to Market Vyleesi   Benzinga
Jul 24, 2020
12:04PM EDT  Why AMAG's Stock Is Moving Today   Benzinga
11:32AM EDT  AMAG Pharmaceuticals shares are trading higher after the company on Thursday announced it has entered into an exclusive licensing agreement with B.V. to commercialize Ciraparantag in Europe, Australia and New Zealand.   Benzinga
Jul 23, 2020
07:16AM EDT  AMAG Pharmaceuticals And Norgine B.V. Enter Into Exclusive Licensing Agreement To Commercialize Ciraparantag In Europe, Australia And New Zealand; AMAG Receives $30M Upfront Payment, Eligible For Up To $260M In Milestones   Benzinga
07:14AM EDT  Agreement provides AMAG with $30 million upfront payment and eligibility to receive up to $260 million in development and commercial milestones in addition to sales royalties   GlobeNewswire Inc
Jul 12, 2020
11:16AM EDT  AMAG : Two Phase 2 Studies Using Ciraparantag Show Efficacy And Safety In Reversal Of Apixaban And Rivaroxaban   RTTNews
08:30AM EDT  AMAG Announces Presentation of Ciraparantag Data at the   GlobeNewswire Inc


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC